Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
Trichomoniasis01:18

Trichomoniasis

Trichomonas vaginalis is a flagellated protozoan parasite and the causative agent of trichomoniasis, one of the most prevalent non-viral sexually transmitted infections in the United States. This extracellular parasite primarily colonizes the lower genitourinary tract in women—particularly the vagina—and in men, the urethra and prostate. Its structural and functional adaptations enable its survival, motility, and pathogenicity within the host environment.Structural Features and Host EntryT.
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Urinary Tract Infection II: Pathophysiology01:25

Urinary Tract Infection II: Pathophysiology

The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
Urinary Tract Infection IV: Nursing Management01:17

Urinary Tract Infection IV: Nursing Management

In managing urinary tract infections (UTIs) in nursing, a comprehensive assessment is essential. Begin by gathering subjective data, such as the patient’s complaints of dysuria (painful urination), urinary frequency, urgency, suprapubic pain, and any lower abdominal discomfort. This information can be complemented by questions regarding previous UTIs, sexual activity, and personal hygiene practices, which can provide insight into risk factors. Objective assessment should focus on signs like...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Therapeutic efficacy and safety of monotherapy Alfuprost MR 10 mg/day in clinical practice].

Urologiia (Moscow, Russia : 1999)·2022
Same author

[Assessment of the safety and efficacy of medicinal product PPR-001 based on regulatory polypeptides of the testes].

Urologiia (Moscow, Russia : 1999)·2021
Same author

[LUTS/BPH who treats?. The results of the epidemiologic study].

Urologiia (Moscow, Russia : 1999)·2019
Same author

[Results of open and laparoscopic partial nephrectomy for localized renal cancer].

Urologiia (Moscow, Russia : 1999)·2018
Same author

[Technical features of intestinal ureteroplasty. art 6: simultaneous ureteral and bladder substitution].

Urologiia (Moscow, Russia : 1999)·2017
Same author

[Innovative activity of dental faculty staff of Omsk State Medical University: results, problems and prospects].

Stomatologiia·2016

Related Experiment Video

Updated: Jun 7, 2026

Measurement of Tactile Allodynia in a Murine Model of Bacterial Prostatitis
06:46

Measurement of Tactile Allodynia in a Murine Model of Bacterial Prostatitis

Published on: January 16, 2013

[Immunocorrecting therapy of chronic bacterial prostatitis].

A I Novikov, V V Zaezzhalkin, V A Kucherov

    Urologiia (Moscow, Russia : 1999)
    |October 26, 2010
    PubMed
    Summary

    Panavir, an immunomodulator, significantly improved treatment outcomes for recurrent chronic bacterial prostatitis (RCBP) when added to standard therapy. This adjuvant therapy is recommended for patients with RCBP and interferon status disorders.

    More Related Videos

    Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
    11:02

    Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

    Published on: October 30, 2013

    Related Experiment Videos

    Last Updated: Jun 7, 2026

    Measurement of Tactile Allodynia in a Murine Model of Bacterial Prostatitis
    06:46

    Measurement of Tactile Allodynia in a Murine Model of Bacterial Prostatitis

    Published on: January 16, 2013

    Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
    11:02

    Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

    Published on: October 30, 2013

    Area of Science:

    • Urology
    • Immunology
    • Pharmacology

    Background:

    • Recurrent chronic bacterial prostatitis (RCBP) affects patients aged 20-59.
    • RCBP is associated with significant interferon status disorders.
    • Standard treatment efficacy for RCBP can be limited.

    Purpose of the Study:

    • To evaluate the efficacy of the immunomodulator panavir as an adjuvant therapy for RCBP.
    • To assess the impact of panavir on immunological and subjective parameters in RCBP patients.

    Main Methods:

    • A randomized controlled trial involving 55 patients with RCBP.
    • Study group (n=40) received standard treatment plus panavir.
    • Control group (n=15) received standard treatment only.
    • Evaluated blood count, prostatic secretion, immunological status, and subjective parameters.

    Main Results:

    • Patients with RCBP exhibited marked disorders of interferon status.
    • The addition of panavir to standard treatment significantly improved treatment results.
    • Panavir demonstrated positive effects on immunological and subjective parameters.

    Conclusions:

    • Panavir is a recommended adjuvant therapy for combined treatment of RCBP.
    • Adjuvant panavir therapy can effectively manage interferon status disorders in RCBP patients.
    • Panavir offers a promising approach to enhance conventional RCBP treatment strategies.